Harvard Biotech Career Fair 2013

Starts:
1:00 pm on Monday, September 30, 2013
Ends:
5:00 pm on Monday, September 30, 2013
Location:
New Research Building (3rd floor Rotunda), Harvard Medical School 77 Avenue Louis Pasteur, Boston, 02115
The Harvard Biotech Career Fair 2013 is here!
The biggest career event for life science PhDs, MDs and PostDoc's, organized by the Harvard Biotech Club. Come speak with key recruitment personnel from industry leaders in the fields of Pharma, Biotech, Consulting, Healthcare Services, Patent Law and Medical Devices. This is an excellent opportunity to network with company representatives, and land the perfect job! The career fair will also include a career discussion panel led by industry experts and a keynote address by Dr. Robert Gould, President and CEO, Epizyme inc.

Schedule of Events:
BIOTECH HIRING ROUND TABLES
12-1, 1:30-2:30, Bray Room
Confirmed panelists:
–Mark Angelino, PhD, VP of Pharmaceutical Sciences, Bluebird Bio
–Nick Terrett, PhD, Chief Scientific Officer, Ensemble Therapeutics
–Gerhard Koenig, PhD, Senior VP of Research and CSO, EnVivo Pharmaceuticals
–Jean-Luc Bodmer, PhD, Director Vaccine Research, Genocea Biosciences
–John Reynders, PhD, Chief Information Officer, Moderna Therapeutics
–David Dalgarno, PhD, VP of Research Technologies, ARIAD Pharmaceuticals
–Marta Fernandez Suarez, PhD, Assay Development, Daktari Diagnostics
Moderator: Pearl Freier, President, Cambridge BioPartners, Inc.
Submit your questions for the panelists before the event here.

CAREER FAIR COMPANY RECRUITMENT TABLES & COMPANY PRESENTATIONS
1-5pm, 3rd Floor Rotunda
Come and meet key recruitment personnel from industry leaders in the fields of Pharma/Biotech, Consulting, Healthcare Services, Patent Law and Medical Devices. For the complete list of employers, and company presentation schedules please visit our website.

KEYNOTE TALK: DR. ROBERT GOULD, PRESIDENT & CEO, EPIZYME INC.
4:30-5:30pm, Bray Room - Refreshments will be served.
Robert Gould will discuss his career transitions, from his PhD/postdoc and research at Merck, to leading Epizyme during its Initial Public Offering (IPO) earlier this year. Last year, Epizyme was #11 on the Forbes ranking of America's 100 Most Promising Companies -- the only biotech to make it onto the list.

Registration is free for Harvard students and Harvard-affiliated postdoctoral fellows, $20 for non Harvard students, and $40 for professionals. Please pay by cash or check on-site.

For more details on seminars, speakers and companies and schedules please click here.